Spectrum Pharmaceuticals reported 0 in Cost of Sales for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
TG Therapeutics TGTX:US 148K 9K
Abbvie ABBV:US $ 4499M 307M
Alnylam Pharmaceuticals ALNY:US $ 30.26M 7.23M
Amgen AMGN:US $ 1637M 147M
Astellas Pharma 4503:JP Y 62231M 3904M
AstraZeneca AZN:LN 2193M 273M
Bayer BAYN:GR € 4546M 152M
Biogen BIIB:US $ 511.8M 52.1M
Bristol Myers Squibb BMY:US $ 2451M 52M
Coherus Biosciences CHRS:US $ 16.7M 9.18M
Eli Lilly And LLY:US $ 1953.2M 74.6M
Endo International Ordinary Shares ENDP:US $ 313.43M 23.44M
GlaxoSmithKline GSK:LN 2519M 108M
Intercept Pharmaceuticals ICPT:US $ 0.62M 0.19M
Johnson & Johnson JNJ:US $ 7250M 317M
Karyopharm Therapeutics KPTI:US $ 1.14M 205K
Merk MRK:US $ 2684M 771M
Novartis NOVN:VX SF 3754M 79M
Pfizer PFE:US $ 6992M 2820M
Puma Biotechnology PBYI:US $ 11.97M 17.59M
Seattle Genetics SGEN:US $ 78.09M 13.96M
Takeda 4502:JP Y 241264M 12182M
Teva Pharmaceutical TEVA:IT 1.99B 76M
YTE INCY:US $ 32.63M 8.81M